Cryptocurrency Analysis and News Portal
Affected by reduced demand for Covid drug Molnupiravir, Merck has published reduced revenue figures according to its Q1 2023 report. Multinational pharmaceutical giant Merck & Co Inc (NYSE: MRK) has released its Q1 2023 report. The company’s figures show a reduction in revenue due to several factors, including a plunge in
Read More
The deal with OncoImmune will see Merck take up the ownership of CD24Fc with additional payment made to OncoImmune based on future favorable regulatory approvals associated with the drug.American multinational pharmaceutical company Merck & Co Inc (NYSE: MRK) has inked a $425 million deal with OncoImmune, a privately-held, clinical-stage biopharmaceutical
Read More
IBM, Merck, Walmart and KPMG’s drug-tracing blockchain pilot exceeded the interoperability benchmarks set by the Food and Drug Administration, the group said. Source
Read More